KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Current Deferred Revenue (2018 - 2025)

Fulgent Genetics (FLGT) has disclosed Current Deferred Revenue for 8 consecutive years, with $3.6 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue rose 62.71% to $3.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Dec 2025, up 62.71% year-over-year, with the annual reading at $3.6 million for FY2025, 62.71% up from the prior year.
  • Current Deferred Revenue hit $3.6 million in Q4 2025 for Fulgent Genetics, up from $2.3 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $14.6 million in Q4 2021 to a low of $2.2 million in Q4 2024.
  • Historically, Current Deferred Revenue has averaged $5.3 million across 5 years, with a median of $2.8 million in 2023.
  • Biggest five-year swings in Current Deferred Revenue: surged 3044.14% in 2021 and later plummeted 80.62% in 2023.
  • Year by year, Current Deferred Revenue stood at $14.6 million in 2021, then plummeted by 78.04% to $3.2 million in 2022, then fell by 10.16% to $2.9 million in 2023, then decreased by 22.27% to $2.2 million in 2024, then surged by 62.71% to $3.6 million in 2025.
  • Business Quant data shows Current Deferred Revenue for FLGT at $3.6 million in Q4 2025, $2.3 million in Q3 2025, and $2.7 million in Q2 2025.